Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cholangiocarcinoma 2020: the next horizon in mechanisms and management
Jesús M. Bañales, José J.G. Marı́n, Ángela Lamarca, et al.
Nature Reviews Gastroenterology & Hepatology (2020) Vol. 17, Iss. 9, pp. 557-588
Open Access | Times Cited: 1685

Showing 51-75 of 1685 citing articles:

First-line Chemotherapy in Advanced Biliary Tract Cancer Ten Years After the ABC-02 Trial: “And Yet It Moves!”
Alessandro Rizzo, Giovanni Brandi
Cancer Treatment and Research Communications (2021) Vol. 27, pp. 100335-100335
Open Access | Times Cited: 80
Pitfalls, challenges, and updates in adjuvant systemic treatment for resected biliary tract cancer
Alessandro Rizzo, Giovanni Brandi
Expert Review of Gastroenterology & Hepatology (2021) Vol. 15, Iss. 5, pp. 547-554
Closed Access | Times Cited: 78
Pemigatinib: Hot topics behind the first approval of a targeted therapy in cholangiocarcinoma
Alessandro Rizzo, Angela Dalia Ricci, Giovanni Brandi
Cancer Treatment and Research Communications (2021) Vol. 27, pp. 100337-100337
Open Access | Times Cited: 76
Molecular Characterization of Biliary Tract Cancer Predicts Chemotherapy and Programmed Death 1/Programmed Death‐Ligand 1 Blockade Responses
Jihoon G. Yoon, Min Hwan Kim, Mi Jang, et al.
Hepatology (2021) Vol. 74, Iss. 4, pp. 1914-1931
Closed Access | Times Cited: 68
Thrombospondin 1 and 2 along with PEDF inhibit angiogenesis and promote lymphangiogenesis in intrahepatic cholangiocarcinoma
Guido Carpino, Vincenzo Cardinale, Alessandra Di Giamberardino, et al.
Journal of Hepatology (2021) Vol. 75, Iss. 6, pp. 1377-1386
Closed Access | Times Cited: 63
New insights on the role of vascular endothelial growth factor in biliary pathophysiology
Valeria Mariotti, Romina Fiorotto, Massimiliano Cadamuro, et al.
JHEP Reports (2021) Vol. 3, Iss. 3, pp. 100251-100251
Open Access | Times Cited: 61
Next-generation sequencing of bile cell-free DNA for the early detection of patients with malignant biliary strictures
María Arechederra, María Rullán, Irene Amat, et al.
Gut (2021) Vol. 71, Iss. 6, pp. 1141-1151
Open Access | Times Cited: 61
Association of gut microbiome and primary liver cancer: A two‐sample Mendelian randomization and case–control study
Jun Ma, Jialiang Li, Jin Chen, et al.
Liver International (2022) Vol. 43, Iss. 1, pp. 221-233
Closed Access | Times Cited: 61
The progress of immune checkpoint therapy in primary liver cancer
Yi-Min Zheng, Siwei Wang, Jia‐Bin Cai, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2021) Vol. 1876, Iss. 2, pp. 188638-188638
Closed Access | Times Cited: 60
Multimodal single-cell profiling of intrahepatic cholangiocarcinoma defines hyperactivated Tregs as a potential therapeutic target
Giorgia Alvisi, Alberto Termanini, Cristiana Soldani, et al.
Journal of Hepatology (2022) Vol. 77, Iss. 5, pp. 1359-1372
Open Access | Times Cited: 60
Cell of origin in biliary tract cancers and clinical implications
Agrin Moeini, Philipp K. Haber, Daniela Sia
JHEP Reports (2021) Vol. 3, Iss. 2, pp. 100226-100226
Open Access | Times Cited: 58
Treatment of Intrahepatic Cholangiocarcinoma—A Multidisciplinary Approach
Felix Krenzien, Nora Nevermann, Alina Krombholz, et al.
Cancers (2022) Vol. 14, Iss. 2, pp. 362-362
Open Access | Times Cited: 54
Clinical relevance of biomarkers in cholangiocarcinoma: critical revision and future directions
Rocı́o I.R. Macı́as, Vincenzo Cardinale, Timothy J. Kendall, et al.
Gut (2022), pp. gutjnl-327099
Open Access | Times Cited: 51
Modelling immune cytotoxicity for cholangiocarcinoma with tumour-derived organoids and effector T cells
Guoying Zhou, Ruby Lieshout, Gilles S. van Tienderen, et al.
British Journal of Cancer (2022) Vol. 127, Iss. 4, pp. 649-660
Open Access | Times Cited: 50
Secondary IDH1 resistance mutations and oncogenic IDH2 mutations cause acquired resistance to ivosidenib in cholangiocarcinoma
James M. Cleary, Betty Rouaisnel, Antoine Daina, et al.
npj Precision Oncology (2022) Vol. 6, Iss. 1
Open Access | Times Cited: 50
Up-to-Date Pathologic Classification and Molecular Characteristics of Intrahepatic Cholangiocarcinoma
Taek Chung, Young Nyun Park
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 49
CircNFIB inhibits tumor growth and metastasis through suppressing MEK1/ERK signaling in intrahepatic cholangiocarcinoma
Jinpeng Du, Tian Lan, Haotian Liao, et al.
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 44
Biology of IDH mutant cholangiocarcinoma
Meng‐Ju Wu, Lei Shi, Joshua Merritt, et al.
Hepatology (2022) Vol. 75, Iss. 5, pp. 1322-1337
Closed Access | Times Cited: 40
Advances of cancer-associated fibroblasts in liver cancer
Hao Peng, Erwei Zhu, Yewei Zhang
Biomarker Research (2022) Vol. 10, Iss. 1
Open Access | Times Cited: 40
JUND/linc00976 promotes cholangiocarcinoma progression and metastasis, inhibits ferroptosis by regulating the miR-3202/GPX4 axis
Shan Lei, Wenpeng Cao, Zhirui Zeng, et al.
Cell Death and Disease (2022) Vol. 13, Iss. 11
Open Access | Times Cited: 39
Tertiary lymphoid structures predict the prognosis and immunotherapy response of cholangiocarcinoma
Taiyu Shang, Tianyi Jiang, Tao Lü, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 39
Cisplatin in Liver Cancer Therapy
Sae Hamaya, Kyoko Oura, Asahiro Morishita, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 13, pp. 10858-10858
Open Access | Times Cited: 39
Artificial intelligence in liver cancers: Decoding the impact of machine learning models in clinical diagnosis of primary liver cancers and liver cancer metastases
Anita K. Bakrania, Narottam Joshi, Xun Zhao, et al.
Pharmacological Research (2023) Vol. 189, pp. 106706-106706
Open Access | Times Cited: 38
Effects and Mechanisms of Kaempferol in the Management of Cancers through Modulation of Inflammation and Signal Transduction Pathways
Ahmad Almatroudi, Khaled S. Allemailem, Wanian M. Alwanian, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 10, pp. 8630-8630
Open Access | Times Cited: 38
Epidemiology of cholangiocarcinoma
Maria Qurashi, Mathew Vithayathil, Shahid A. Khan
European Journal of Surgical Oncology (2023), pp. 107064-107064
Open Access | Times Cited: 38

Scroll to top